Literature DB >> 10692051

Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.

A Basu1, G Chakrabarti, A Saha, S Bandyopadhyay.   

Abstract

BALB/c mice resolve Leishmania donovani infection in the liver over an 8-12-week period. However, after an initial phase of 2-4 weeks where increases in parasite load are not readily detectable, parasite numbers in the spleen begin to increase reaching maximum levels at 16 weeks post-infection. Thereafter, parasite replication in the spleen is controlled and BALB/c mice maintain this residual parasite load in the spleen for many months, without further increase. We evaluated functions of CD11C+ splenic dendritic cells throughout the course of L. donovani infection in the spleen of BALB/c mice. Unlike the dendritic cell (DC)-specific antigen DEC-205, CD11C was not up-regulated on macrophages during visceral leishmaniasis. No appreciable impairment of splenic DC functions was observed when this antigen-presenting cell subset was purified from 30-day post-infected mice. Significant impairment in inducing allogeneic mixed lymphocyte reaction (MLR) and presenting L. donovani antigens or keyhole limpet haemocyanin (KLH) to specific T cells was observed with CD11C+ splenic DC purified from 60-day post-infected mice. Functional impairment of splenic DC at 60 days post-infection correlated with their reduced surface expression of major histocompatibility complex (MHC) class II molecules, impairment of interleukin-12 (IL-12) production and to their ability to suppress interferon-gamma (IFN-gamma) production by Leishmania antigen-primed T cells. Of interest, the impairment of splenic DC in presenting Leishmania antigens or KLH to specific T cells was corrected at 120 days post-infection, and correlated with their up-regulation of MHC class II expression, IL-12 production, induction of IFN-gamma by Leishmania antigen-primed T cells and the onset of control over splenic parasite replication in vivo. These results indicate that functional integrity of DC may be important in controlling L. donovani infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692051      PMCID: PMC2327141          DOI: 10.1046/j.1365-2567.2000.00939.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Detection of enhanced cytotoxic T lymphocyte response with spleenic dendritic cells enriched by a simple sequential adherence method.

Authors:  K U Saikh; A H Nishikawa; S B Dillon
Journal:  Viral Immunol       Date:  1996       Impact factor: 2.257

2.  Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.

Authors:  H W Murray; H Masur; J S Keithly
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

3.  Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.

Authors:  P M Gorak; C R Engwerda; P M Kaye
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

4.  Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.

Authors:  H Moll; S Flohé; M Röllinghoff
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

Review 5.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon.

Authors:  P P Manna; D Bharadwaj; S Bhattacharya; G Chakrabarti; D Basu; K K Mallik; S Bandyopadhyay
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products.

Authors:  N E Reiner; W Ng; W R McMaster
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

9.  Leishmania donovani: amastigote inhibition and mode of action of berberine.

Authors:  A K Ghosh; F K Bhattacharyya; D K Ghosh
Journal:  Exp Parasitol       Date:  1985-12       Impact factor: 2.011

10.  Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.

Authors:  S Bandyopadhyay; B Perussia; G Trinchieri; D S Miller; S E Starr
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Compartmentalization of dendritic cell and T-cell interactions in the lymph node: Anatomy of T-cell fate decisions.

Authors:  Beatriz León; Frances E Lund
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

2.  Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection.

Authors:  Laís Sacramento; Silvia C Trevelin; Manuela S Nascimento; Djalma S Lima-Jùnior; Diego L Costa; Roque P Almeida; Fernando Q Cunha; João S Silva; Vanessa Carregaro
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

3.  Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major.

Authors:  Eric Muraille; Carl De Trez; Bernard Pajak; Fabiola Aguilar Torrentera; Patrick De Baetselier; Oberdan Leo; Yves Carlier
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.

Authors:  Asher Maroof; Paul M Kaye
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

5.  Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.

Authors:  Joseph L Amprey; Gerald F Späth; Steven A Porcelli
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 6.  Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  Front Immunol       Date:  2014-06-26       Impact factor: 7.561

7.  Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.

Authors:  Maria Agallou; Evita Athanasiou; Olga Koutsoni; Eleni Dotsika; Evdokia Karagouni
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

8.  Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype.

Authors:  Guadalupe Andreani; Michel Ouellet; Rym Menasria; Alejandro Martin Gomez; Corinne Barat; Michel J Tremblay
Journal:  PLoS Negl Trop Dis       Date:  2015-02-24

Review 9.  Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.

Authors:  Greta Volpedo; Thalia Pacheco-Fernandez; Parna Bhattacharya; Timur Oljuskin; Ranadhir Dey; Sreenivas Gannavaram; Abhay R Satoskar; Hira L Nakhasi
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.